#CBCF24 great day 1 with the participation of leaders in the research and treatment of bladder cancer BladderCancerCanada KSridhar Nimira Alimohamed Lum Lab Maria Jiang Girish Kulkarni Peter Black Wes Kassouf

All eyes & ears at #CBCF24 and Elizabeth Plimack MD for her presentation: Antibody-Drug Conjugates Emerging Data for Efficacy, thank you for your virtual presentation. Wes Kassouf Peter Black Girish Kulkarni Nimira Alimohamed KSridhar

Honoured that our PROGRxN-BCa study was selected as the Best of #EAU24 Abstracts: Urothelial Ca! Girish Kulkarni Univ of Toronto Urology
Temerty Centre for AI in Medicine (T-CAIREM)

Many thanks to our 🇨🇦 collaborators for making this possible! Wes Kassouf Peter Black Rod Breau & many others not on X!

#CUAproud Canadian Urological Association

Development of the bladder utility symptom scale (BUSS Utility): A novel tool to measure utilities and quality of life in #BladderCancer patients. Presented by Girish Kulkarni University of Toronto. #EAU24 written coverage by Zach Klaassen Georgia Cancer Center on UroToday > bit.ly/3U4W4QU European Association of Urology (EAU)

#EAU24 Development of the Bladder Utility Symptom Scale (BUSS Utility) Girish Kulkarni
UroToday.com

📌n=200 BCa pts, n=200 community
📌10-item questionnaire
📌Final model weighted correlation coefficient between predicted and observed utilities: 0.733 community, 0.734 BCa pts

With Matt Galsky #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT & 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.

Looking forward to sharing our work at #EAU24 in Paris, thanks to the mentorship of Girish Kulkarni and Dr. Alexandre Zlotta, with tremendous support from Univ of Toronto Urology, Temerty Centre for AI in Medicine (T-CAIREM), BladderCancerCanada, and Canadian Urological Association!

#EAU24 Do not miss the Joint Session of the European Association of Urology (EAU) and the Canadian Urological Association (CUA). Details for registration:
eaucongress.uroweb.org/registration/
AND also come say bonjour to your Canadian colleagues at booth L58.
🇫🇷 🇨🇦 #CUA24
Peter Black

Thank you to all the faculty for a successful 2-days discussing cancer care in #urology at the 24th Canadian Senior Resident Uro-oncology Course. Canadian Urological Association McGill University Philippe spiess

MSc defense done! ✅

So grateful for the mentorship of my phenomenal co-supervisors Girish Kulkarni Alistair Johnson, & amazing committee members Drs. Alexandre Zlotta, Melissa McCradden, & Muhammad Mamdani. Special thanks to my examiners Stephen Boorjian, MD & Jeremy Petch for their invaluable feedback!

Benefit across all subgroups! Tom Powles Shilpa Gupta Petros Grivas Bladder Cancer Advocacy Network

OS data for adjuvant nivolumab in bladder cancer #EAU24 (CM274). Atezo & pembro have been -ve for OS. What will nivo do? Also the risk of radiological relapse in ctDNA -ve post cystectomy (IM011). These are important to improve outcomes in MIBC. Progress in UC NIXON URBAIN Daniele?

TiP: KEYNOTE-057 Cohort C: Pembro + vibostolimab (T-cell immunoglobulin and ITIM domain inhibitor) & pembro + favezelimab (lymphocyte activation gene 3 inhibtor) for BCG unresponsive CIS +/- papillary
🔷Primary: 12 months CR (biopsy mandated)
🔷Secondary: 3 & 6 mo CR, overall CR,

Hope to see you all here. Pass on the word! Canadian Urological Association

It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2023: Some negative, some positive, but we learned from all!

Feel free to add more & retweet & tag

This is not an exhaustive list!

OncoAlert @danafarber Dana-Farber_GU

#OnwardFor2024

A big day for bladder ca patients U.S. FDA. Massive team effort. Platinum based chemo superseded at last. EV/pembro will transform the lives of many pts with this difficult disease. Still lots to do but it’s a pretty good day and worth pausing for a moment. bit.ly/3GLntQn

So excited to partner with Princess Margaret Cancer Centre Cancer Network to ensure our patients, community and health care team members Oak Valley Health are connected to world class cancer care! thanks Keith Stewart Elena Pacheco Jo-anne Marr for this great partnership!

Happy Diwali at THP Diwali Gala!

Anil Kapoor was a gifted surgeon with a bedside manner that put everyone at ease theglobeandmail.com/life/article-a…

JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!

The time has finally come... via Business Wire

Dana-Farber Lank Center for Genitourinary Oncology Tom Powles OncoAlert Oncology Brothers OncLive.com Targeted Oncology UroToday.com Uromigos Alliance for Clinical Trials in Oncology ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network